ISTO Technologies Names George Dunbar as President and CEO [Professional Services Close - Up]
(Professional Services Close - Up Via Acquire Media NewsEdge) ISTO Technologies, Inc., an orthobiological regenerative medicine company, announced that George Dunbar was appointed President and Chief Executive Officer, effective immediately.
According to a release, Mitchell Seyedin will continue to serve the Company in the newly-created role as Executive Chairman and will remain on the Board.
Dunbar joins ISTO from Arboretum Ventures. Prior to joining Arboretum, Dunbar was president, chief executive officer, and later chairman of Aastrom Biosciences. He held senior positions with The Ares-Serono Group and Amersham International.
"George Dunbar's proven leadership and broad experience, along with his recognized skill as a strategic change agent, will help build value for ISTO and drive wider recognition of our cell-based cartilage products, as well as other products in clinical development that are soon to be introduced," said Mitchell Seyedin. "His entrepreneurial approach to building healthcare and bioscience companies, as well as his emphasis on individual and team accountability, makes him superbly suited to this role. We are pleased to have him as a member of our senior management team."
Dunbar held broad operating and director roles at DepoTech, Epic Therapeutics, LJL Biosystems, Metrika, Molecular Probes, StemCells, Inc., Quantum Dot and Quidel.
((Comments on this story may be sent to firstname.lastname@example.org))
(c) 2014 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To TMCnet.com's Homepage ]